The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Phar
Guidelines for management of urgent symptoms in cholangiocarcinoma (CC) patients (pts) with biliary stents or catheters using the modified RAND/UCLA Delphi process.
 
Renuka V. Iyer
Honoraria - Ipsen
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Ipsen; Lexicon; Novartis
Research Funding - Genentech/Roche (Inst); Ipsen (Inst); Lilly (Inst)
 
Susan G. Acquisto
No Relationships to Disclose
 
John A. Bridgewater
Honoraria - Merck Serono; SERVIER
Consulting or Advisory Role - Merck Serono; Roche; SERVIER
Speakers' Bureau - Celgene
Travel, Accommodations, Expenses - Merck Serono; MSD Oncology; SERVIER
 
Michael A. Choti
No Relationships to Disclose
 
Theodore S. Hong
Research Funding - Novartis (Inst); Taiho Pharmaceutical
 
Bela Kis
No Relationships to Disclose
 
Peter A Mead
No Relationships to Disclose
 
Lewis R. Roberts
No Relationships to Disclose
 
Rebecca Roberts
No Relationships to Disclose
 
Neehar D. Parikh
No Relationships to Disclose
 
Jason K. Sicklick
Consulting or Advisory Role - Sirtex Medical (Inst)
Research Funding - Blueprint Medicines; Foundation Medicine; Novartis
 
Richard S. Siegel
No Relationships to Disclose
 
Jonathan R. Whisenant
No Relationships to Disclose
 
Dasha Cherepanov
No Relationships to Disclose
 
Michael Broder
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Genentech; Novartis
Other Relationship - Amgen; Bard Medical; Boston Scientific; Bristol-Myers Squibb; Celgene; Eisai; Genentech; Genomic Health; Helsinn Healthcare; Ipsen; Jazz Pharmaceuticals; Johnson & Johnson; Lilly; Novartis; Onconova Therapeutics; Otsuka; Shionogi
 
Juan W. Valle
Consulting or Advisory Role - Agios; AstraZeneca; Baxalta; Delcath Systems; Ipsen; Lilly; Merck; Midatech Pharma; Novartis; Pfizer
Speakers' Bureau - Celgene; Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Lilly; Novartis